SlideShare a Scribd company logo
Anesthesia for Living Donor Renal
Transplantation
DR:IBRAHIM HASSAAN,MBCHB,MSC,EDAIC
07/07/2023
A-Preoperative Assessment specific to Chronic Kidney
Disease
History
• Assess underlying condition—DM,HTN etc (controlled,
medication,complications)
• Symptoms of ESRD: asymptomatic, fatigue, weakness, confusion, nausea,
vomiting, paresthesias, dyspnea, pruritus, nocturia, reduced urine output
• Comorbid disease
• Previous abdominal surgery (scarring/adhesions can make dissection difficult
and increase blood loss)
1-Current renal replacement therapy
How intraperitoneal/ hemodialysis /When done?
2-Volume status, current weight, dry weight?
3- Electrolytes?
4-Vascular access sites, current and past, fistula ?
5-Planned post operative dialysis
 Medication history:
- high-dose ACE inhibitors should be withheld perioperatively unless there is left
ventricular dysfunction.
- beta-blockers, statins and aspirin should not be stopped perioperatively.
- continue diuretics in the perioperative period.
Physical Exam
 ESRD: altered mental status, neuropathies, hyperreflexia, seizures, weight loss, HTN,
dependent edema, orthostatic hypotension
• Sites for IV access, central access
 -Gastrointestinal
 -peripheral neuropathy, autonomic neuropathy
 -Haematological – anaemia, thrombocytopenia, coagulopaty
 -Endocrine/ metabolic – Hyperparathyroidism, Mg,Na,Cl
 acidosis, impaired thermoregulation, hypervolaemia (compare to patient’s dry weight)
 -Immunological – decreased immune function, intercurrent infection, Hepatitis C
infection from dialysis,
 -Vascular access – fistula sites and functionality, current and previous central venous
access
Lab Tests/Imaging
• CBC, urea/creatinine, electrolytes, glucose, CXR
• ECG, echocardiogram
B-Anesthetic care
Preop-
- AV fistula wrapped and padded. Patency checked at regular
intervals.
-monitors
 Arterial line, blood pressure cuff placed on the opposite side
 Monitoring central venous access, ECG with ST segment
monitoring, neuromuscular and temperature.
 Induction
GA/ETT with RSI as required
- Aim normothermic, normotensive, normal intravascular volume.
- Target CVP >10-12 mmHg, If PAC insitu target pulmonary artery diatolic
pressure >15mmHg
- Typical volume required 60-100 ml/kg
- Type of fluids less important
- Prompt replacement of blood if sudden massive haemorrhage to preserve
kidney perfusion
How can the function of the transplanted
kidney be optimized intraoperatively?
 General measures
- General anaesthesia with paralysis and ventilation allows better haemodynamic
control and muscle relaxation than that of regional anaesthesia.
This also avoids the risk of coughing and anastomotic breakdown.
- Maintain normothermia, normoxia, normocapnia, normoglycaemia
 Specific to renal transplant
- MAP of 90mmHg ;aim is to maintain adequate hydration and renal perfusion (adjusted
higher for Maintain normotension at the time of graft arterial clamp removal to
optimise graft perfusion.
- Maintain a CVP of 12-14cm H2O at the time of graft perfusion.
- Cardiac output monitoring to guide fluid management.
-Liberal fluid administration at the beginning of surgery but keeping
total infusion volumes less than 2.5L.
- Blood transfusion with a transfusion target of 70g/L will improve
oxygen delivery to the transplanted kidney.
Drugs to improve graft function
- Dopamine as an infusion to improve renal blood flow
- Furosemide (40-250mg IV) as a bolus prior to reperfusion to promote diuresis,
renal blood flow and avoid oliguria.
- Mannitol (0.5g/kg IV) as a bolus prior to reperfusion to increase intravascular
volume and improve renal blood flow
C-Postoperative
 PACU or ICU as required
• Monitor for bleeding, metabolic dysfunction
•Treat hypotension hypovolemia, monitor arterial and central venous pressure
Isotonic 0.9% saline at 30ml/hr plus previous hour urine output
Pain Management
 PCA morphine used with care, epidural can be used, avoid hypotension.
 TAP block with multimodal analgesia can be adequate.
Common Postoperative Analgesic drugs
should be Avoided
Non-steroidal anti-inflammatory drugs are contraindicated
as they inhibit prostaglandin synthesis and therefore reduce renal blood
flow and glomerular filtration autoregulation.
Cyclo-oxygenase 2 inhibitors should also be avoided due a similar
mechanism.

More Related Content

Similar to Renal transplantation.pptx

Anaesthesia for liver transplantation
Anaesthesia for liver transplantationAnaesthesia for liver transplantation
Anaesthesia for liver transplantation
isakakinada
 
Turp CASE FINAL.pptx
Turp CASE FINAL.pptxTurp CASE FINAL.pptx
Turp CASE FINAL.pptx
JeyRaj4
 
Management of acute kidney injury
Management of acute kidney injuryManagement of acute kidney injury
Management of acute kidney injury
Mohammed Ahmed
 
ANAESTHESIA FOR PATIENTS WITH RENAL FAILURE.pptx
ANAESTHESIA FOR PATIENTS WITH RENAL FAILURE.pptxANAESTHESIA FOR PATIENTS WITH RENAL FAILURE.pptx
ANAESTHESIA FOR PATIENTS WITH RENAL FAILURE.pptx
SweetPotatoe1
 
Intravascular_Fluid_Therapy_anesthesia__b7ca9904.ppt
Intravascular_Fluid_Therapy_anesthesia__b7ca9904.pptIntravascular_Fluid_Therapy_anesthesia__b7ca9904.ppt
Intravascular_Fluid_Therapy_anesthesia__b7ca9904.ppt
ssuserd1e243
 

Similar to Renal transplantation.pptx (20)

Perioperative care
Perioperative carePerioperative care
Perioperative care
 
ARF- acute renal failure
ARF- acute renal failureARF- acute renal failure
ARF- acute renal failure
 
Anaesthesia for liver transplantation
Anaesthesia for liver transplantationAnaesthesia for liver transplantation
Anaesthesia for liver transplantation
 
Anaesthesia for renal transplant
Anaesthesia for renal transplantAnaesthesia for renal transplant
Anaesthesia for renal transplant
 
Periop fluid th ent 7.2021.a
Periop fluid th   ent 7.2021.aPeriop fluid th   ent 7.2021.a
Periop fluid th ent 7.2021.a
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
AKI IN ICU.pptx
AKI IN ICU.pptxAKI IN ICU.pptx
AKI IN ICU.pptx
 
Acute Kidney Injury; A case study with detailed etiology and management
Acute Kidney Injury; A case study with detailed etiology and managementAcute Kidney Injury; A case study with detailed etiology and management
Acute Kidney Injury; A case study with detailed etiology and management
 
Turp CASE FINAL.pptx
Turp CASE FINAL.pptxTurp CASE FINAL.pptx
Turp CASE FINAL.pptx
 
Hepatorenal
HepatorenalHepatorenal
Hepatorenal
 
Renal system
Renal systemRenal system
Renal system
 
CRRT
CRRTCRRT
CRRT
 
Management of acute kidney injury
Management of acute kidney injuryManagement of acute kidney injury
Management of acute kidney injury
 
Aki2020
Aki2020Aki2020
Aki2020
 
ANAESTHESIA FOR PATIENTS WITH RENAL FAILURE.pptx
ANAESTHESIA FOR PATIENTS WITH RENAL FAILURE.pptxANAESTHESIA FOR PATIENTS WITH RENAL FAILURE.pptx
ANAESTHESIA FOR PATIENTS WITH RENAL FAILURE.pptx
 
Intravascular_Fluid_Therapy_anesthesia__b7ca9904.ppt
Intravascular_Fluid_Therapy_anesthesia__b7ca9904.pptIntravascular_Fluid_Therapy_anesthesia__b7ca9904.ppt
Intravascular_Fluid_Therapy_anesthesia__b7ca9904.ppt
 
Intravascular_Fluid_Therapy_anesthesia__b7ca9904.ppt
Intravascular_Fluid_Therapy_anesthesia__b7ca9904.pptIntravascular_Fluid_Therapy_anesthesia__b7ca9904.ppt
Intravascular_Fluid_Therapy_anesthesia__b7ca9904.ppt
 
Aki
AkiAki
Aki
 

More from Dr.Ibrahim Hassaan (13)

Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptx
 
ENDOCRINE PHYSIOLOGY.pptx
ENDOCRINE PHYSIOLOGY.pptxENDOCRINE PHYSIOLOGY.pptx
ENDOCRINE PHYSIOLOGY.pptx
 
Diuretics.pptx
Diuretics.pptxDiuretics.pptx
Diuretics.pptx
 
antiarrythmic.pptx
antiarrythmic.pptxantiarrythmic.pptx
antiarrythmic.pptx
 
INTRAOPERATIVE CRITICAL INCIDENTS.pptx
INTRAOPERATIVE CRITICAL  INCIDENTS.pptxINTRAOPERATIVE CRITICAL  INCIDENTS.pptx
INTRAOPERATIVE CRITICAL INCIDENTS.pptx
 
Anatomy & physiology of Brain,Spinl cord Nerve,Eye.pptx
Anatomy & physiology of Brain,Spinl cord Nerve,Eye.pptxAnatomy & physiology of Brain,Spinl cord Nerve,Eye.pptx
Anatomy & physiology of Brain,Spinl cord Nerve,Eye.pptx
 
Adrenergic receptors and drugs.pptx
Adrenergic receptors and drugs.pptxAdrenergic receptors and drugs.pptx
Adrenergic receptors and drugs.pptx
 
anti depressent drugs.pptx
anti depressent  drugs.pptxanti depressent  drugs.pptx
anti depressent drugs.pptx
 
anti coagulant.pptx
anti coagulant.pptxanti coagulant.pptx
anti coagulant.pptx
 
cvs physiology part 2.pptx
cvs physiology part  2.pptxcvs physiology part  2.pptx
cvs physiology part 2.pptx
 
cvs physiology part1.pptx
cvs physiology part1.pptxcvs physiology part1.pptx
cvs physiology part1.pptx
 
opioid.pptx
opioid.pptxopioid.pptx
opioid.pptx
 
LOCAL ANESTH.pptx
LOCAL ANESTH.pptxLOCAL ANESTH.pptx
LOCAL ANESTH.pptx
 

Recently uploaded

The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
plant breeding methods in asexually or clonally propagated crops
plant breeding methods in asexually or clonally propagated cropsplant breeding methods in asexually or clonally propagated crops
plant breeding methods in asexually or clonally propagated crops
parmarsneha2
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 

Recently uploaded (20)

TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
Solid waste management & Types of Basic civil Engineering notes by DJ Sir.pptx
Solid waste management & Types of Basic civil Engineering notes by DJ Sir.pptxSolid waste management & Types of Basic civil Engineering notes by DJ Sir.pptx
Solid waste management & Types of Basic civil Engineering notes by DJ Sir.pptx
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
 
Jose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptx
Jose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptxJose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptx
Jose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptx
 
plant breeding methods in asexually or clonally propagated crops
plant breeding methods in asexually or clonally propagated cropsplant breeding methods in asexually or clonally propagated crops
plant breeding methods in asexually or clonally propagated crops
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...
50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...
50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
 

Renal transplantation.pptx

  • 1. Anesthesia for Living Donor Renal Transplantation DR:IBRAHIM HASSAAN,MBCHB,MSC,EDAIC 07/07/2023
  • 2.
  • 3.
  • 4. A-Preoperative Assessment specific to Chronic Kidney Disease History • Assess underlying condition—DM,HTN etc (controlled, medication,complications) • Symptoms of ESRD: asymptomatic, fatigue, weakness, confusion, nausea, vomiting, paresthesias, dyspnea, pruritus, nocturia, reduced urine output • Comorbid disease • Previous abdominal surgery (scarring/adhesions can make dissection difficult and increase blood loss)
  • 5. 1-Current renal replacement therapy How intraperitoneal/ hemodialysis /When done? 2-Volume status, current weight, dry weight? 3- Electrolytes? 4-Vascular access sites, current and past, fistula ? 5-Planned post operative dialysis
  • 6.  Medication history: - high-dose ACE inhibitors should be withheld perioperatively unless there is left ventricular dysfunction. - beta-blockers, statins and aspirin should not be stopped perioperatively. - continue diuretics in the perioperative period.
  • 7. Physical Exam  ESRD: altered mental status, neuropathies, hyperreflexia, seizures, weight loss, HTN, dependent edema, orthostatic hypotension • Sites for IV access, central access  -Gastrointestinal  -peripheral neuropathy, autonomic neuropathy  -Haematological – anaemia, thrombocytopenia, coagulopaty  -Endocrine/ metabolic – Hyperparathyroidism, Mg,Na,Cl  acidosis, impaired thermoregulation, hypervolaemia (compare to patient’s dry weight)  -Immunological – decreased immune function, intercurrent infection, Hepatitis C infection from dialysis,  -Vascular access – fistula sites and functionality, current and previous central venous access
  • 8. Lab Tests/Imaging • CBC, urea/creatinine, electrolytes, glucose, CXR • ECG, echocardiogram
  • 9. B-Anesthetic care Preop- - AV fistula wrapped and padded. Patency checked at regular intervals. -monitors  Arterial line, blood pressure cuff placed on the opposite side  Monitoring central venous access, ECG with ST segment monitoring, neuromuscular and temperature.
  • 10.  Induction GA/ETT with RSI as required - Aim normothermic, normotensive, normal intravascular volume. - Target CVP >10-12 mmHg, If PAC insitu target pulmonary artery diatolic pressure >15mmHg - Typical volume required 60-100 ml/kg - Type of fluids less important - Prompt replacement of blood if sudden massive haemorrhage to preserve kidney perfusion
  • 11. How can the function of the transplanted kidney be optimized intraoperatively?  General measures - General anaesthesia with paralysis and ventilation allows better haemodynamic control and muscle relaxation than that of regional anaesthesia. This also avoids the risk of coughing and anastomotic breakdown. - Maintain normothermia, normoxia, normocapnia, normoglycaemia
  • 12.  Specific to renal transplant - MAP of 90mmHg ;aim is to maintain adequate hydration and renal perfusion (adjusted higher for Maintain normotension at the time of graft arterial clamp removal to optimise graft perfusion. - Maintain a CVP of 12-14cm H2O at the time of graft perfusion. - Cardiac output monitoring to guide fluid management. -Liberal fluid administration at the beginning of surgery but keeping total infusion volumes less than 2.5L. - Blood transfusion with a transfusion target of 70g/L will improve oxygen delivery to the transplanted kidney.
  • 13. Drugs to improve graft function - Dopamine as an infusion to improve renal blood flow - Furosemide (40-250mg IV) as a bolus prior to reperfusion to promote diuresis, renal blood flow and avoid oliguria. - Mannitol (0.5g/kg IV) as a bolus prior to reperfusion to increase intravascular volume and improve renal blood flow
  • 14. C-Postoperative  PACU or ICU as required • Monitor for bleeding, metabolic dysfunction •Treat hypotension hypovolemia, monitor arterial and central venous pressure Isotonic 0.9% saline at 30ml/hr plus previous hour urine output Pain Management  PCA morphine used with care, epidural can be used, avoid hypotension.  TAP block with multimodal analgesia can be adequate.
  • 15. Common Postoperative Analgesic drugs should be Avoided Non-steroidal anti-inflammatory drugs are contraindicated as they inhibit prostaglandin synthesis and therefore reduce renal blood flow and glomerular filtration autoregulation. Cyclo-oxygenase 2 inhibitors should also be avoided due a similar mechanism.